Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ABVACC, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-05-17 to 2025-12-16
Current total value of award: $3376141
Description: TO DEVELOP A POTENT THERAPEUTIC MARBURGVIRUS MONOCLONAL ANTIBODY.